ERBB2 and breast cancer: Molecular subtypes of breast cancer, such as HER-2 (Human Epidermal Growth Factor Receptor 2)-positive breast cancer, have biological behaviors and prognostic characteristics that are significantly different from those of other subtypes and, therefore, require more refined treatment and management.